Ballicules.com

Ropivacaine

NAROPIN

What it isLong-acting amide local anesthetic that blocks voltage-gated sodium channels; used for epidural, peripheral nerve, and local infiltration anesthesia.

Why this oneProvides prolonged sensory block with less motor block and less cardiotoxicity than comparable bupivacaine concentrations.

What limits itIntravascular injection or excessive dose causes local-anesthetic systemic toxicity; inject incrementally with aspiration and cardiorespiratory monitoring.

FDA-approved for

FDA label

FDA dosingPopulationStartTargetMax
Surgical anesthesia (epidural, major nerve block, field block)Adults0.5–1% (5–10 mg/mL) per blockPer block; e.g. epidural up to ~200 mg
Labor analgesia / acute postoperative pain (epidural infusion)Adults0.2% (2 mg/mL)Continuous epidural up to 28 mg/hr

Renal Undefined

Hepatic Undefined

Dose varies by block type, site, and patient status; consult the block-specific dosage table.

Instructions

Cautions

Adverse reactions

Pregnancy No human data; crosses the placenta and can cause fetal/neonatal toxicity when used in labor.

Lactation Present in human milk at low levels; no adverse reactions reported in breastfed infants.

NO BOXED WARNINGS

Principal risklocal-anesthetic systemic toxicity from inadvertent intravascular injection

Classes and tags

Clinical profile

Direct muscarinic antagonism0 / 4

Mechanism of action: Ropivacaine ballicule

Ropivacaine ballicule: receptor binding, kinetics and half-life diagram

Open Ropivacaine in the interactive console ↗